Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info


Read Full Text


Download PDF


View Table of Contents

Recurrent Transient Synovitis of the Hip in Childhood. Longterm Outcome Among 39 Patients

YOSEF UZIEL, YONATAN BUTBUL-AVIEL, JUDITH BARASH, SHAI PADEH, MASZA MUKAMEL, NATALIA GORODNITSKI, RIVA BRIK, and PHILIP J. HASHKES

ABSTRACT.

Objective
. To describe the outcome of children with recurrent transient synovitis (TS) of the hip.

Methods. A retrospective chart review of children with at least 2 separate episodes of TS between 1986 and 2003. We described the diagnostic investigations and outcome of these patients. A followup telephone survey for disability and pain scores was performed in 2004.

Results. We studied 39 children, 26 boys and 13 girls, from 6 pediatric rheumatology centers. The mean age at initial episode was 6 ± 2.6 years. There were a total of 102 episodes (mean 2.9 ± 1.6, median 2, range 2–10). All but 2 children had normal plain radiographs of the hip. All patients were contacted 4.2 ± 2.5 years after the first episode. None developed clinical Perthes disease or other chronic orthopedic condition. Three (8%) patients developed chronic disease: one had familial Mediterranean fever and 2 developed spondyloarthropathies, 0.5, 2, and 6 years after presentation. At followup 26 of 36 patients were asymptomatic, and 10 reported rare hip pain after intensive physical effort.

Conclusion. Children with recurrent TS usually have a benign course. In some patients recurrent TS may be the presenting feature of a chronic inflammatory condition. No progression to chronic orthopedic conditions was observed. (J Rheumatol 2006;33:810–11)

Key Indexing Terms:

TRANSIENT SYNOVITIS
RECURRENT
CHILDREN
TOXIC
HIP


From the Department of Pediatrics, Pediatric Rheumatology, Meir Medical Center, Kfar Saba; Tel Aviv University, Tel Aviv; Ha'Emek Medical Center, Afula; Kaplan Medical Center, Rehovot; Hebrew University, Jerusalem; Sheba Medical Center, Ramat Gan; Schneider Children's Hospital, Petah-Tikva; Rambam Medical Center; Technion Medical School, Haifa, Israel; Cleveland Clinic Foundation, Cleveland, Ohio, USA; and the Pediatric Rheumatology Study Group of Israel.

Y. Uziel, MD, MSc, Senior Clinical Lecturer, Pediatric Rheumatology, Department of Pediatrics, Meir Medical Center, Tel Aviv University; Y. Butbul-Aviel, MD, Instructor, Ha'Emek Medical Center; J. Barash, MD, Lecturer, Kaplan Medical Center, Hebrew University; S. Padeh, MD, Senior Clinical Lecturer, Sheba Medical Center, Tel Aviv University; M. Mukamel, MD, Senior Clinical Lecturer, Schneider Children's Hospital, Tel Aviv University; N. Gorodnitski, MD, Pediatric Rheumatology, Department of Pediatrics, Meir Medical Center, Tel Aviv University; R. Brik, MD, Associate Professor of Pediatrics, Rambam Medical Center, Technion Medical School; P.J. Hashkes, MD, MSc, Cleveland Clinic Foundation.

Address reprint requests to Dr. Y. Uziel, Department of Pediatrics, Meir Medical Center, Kfar-Saba, Israel, 44281. E-mail: uziely@zahav.net.il

Accepted for publication November 25, 2005.




Return to April 2006 Table of Contents



© 2006. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.